
    
      This is a 90-day randomized, observer-masked, active-controlled, parallel-group,
      multi-center, study assessing the safety and efficacy of five concentrations of DE-117
      ophthalmic solution when compared to latanoprost (0.005% latanoprost) in subjects with
      primary open-angle glaucoma or ocular hypertension.
    
  